The US OTC hearing aid market has grown enough since starting in 2022 to prompt not only the merger of two leading firms focused on the space, Eargo Inc. and hearX Group, but also a $100m investment in the deal by Eargo’s majority owner, Patient Square Capital.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?